197 related articles for article (PubMed ID: 9046954)
1. Management of benign prostatic hyperplasia.
Barry M; Roehrborn C
Annu Rev Med; 1997; 48():177-89. PubMed ID: 9046954
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
3. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
4. [Value of functional examination techniques for the assessment of the clinical aspects of benign prostatic hyperplasia].
Hohenfellner M; Thüroff JW
Urologe A; 1992 May; 31(3):142-9. PubMed ID: 1377431
[TBL] [Abstract][Full Text] [Related]
5. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
[TBL] [Abstract][Full Text] [Related]
6. [Latest trends and recommendations on epidemiology, diagnosis, and treatment of benign prostatic hyperplasia (BPH)].
Gabuev A; Oelke M
Aktuelle Urol; 2011 May; 42(3):167-78. PubMed ID: 21604233
[TBL] [Abstract][Full Text] [Related]
7. [Contribution of pressure-flow relationship studies in the evaluation of benign hypertrophy of the prostate].
Haab F
Prog Urol; 1999 Feb; 9(1):151-5. PubMed ID: 10212970
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the clinical value of a simple flowmeter in the management of male lower urinary tract symptoms.
Chan CK; Yip SK; Wu IP; Li ML; Chan NH
BJU Int; 2012 Jun; 109(11):1690-6. PubMed ID: 21933332
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
Elshal AM; Elmansy HM; Elhilali MM
BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
[TBL] [Abstract][Full Text] [Related]
10. Outline of JUA clinical guidelines for benign prostatic hyperplasia.
Homma Y; Gotoh M; Yokoyama O; Masumori N; Kawauchi A; Yamanishi T; Ishizuka O; Seki N; Kamoto T; Nagai A; Ozono S;
Int J Urol; 2011 Nov; 18(11):741-56. PubMed ID: 22050351
[TBL] [Abstract][Full Text] [Related]
11. Canadian guidelines for the management of benign prostatic hyperplasia.
Nickel JC; Herschorn S; Corcos J; Donnelly B; Drover D; Elhilali M; Goldenberg L; Grantmyre J; Laroche B; Norman R; Piercy B; Psooy K; Steinhoff G; Trachtenberg J; Saad F; Tanguay S; ;
Can J Urol; 2005 Jun; 12(3):2677-83. PubMed ID: 16011814
[TBL] [Abstract][Full Text] [Related]
12. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).
Madersbacher S; Alivizatos G; Nordling J; Sanz CR; Emberton M; de la Rosette JJ
Eur Urol; 2004 Nov; 46(5):547-54. PubMed ID: 15474261
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and medical management of benign prostatic hyperplasia.
Beckman TJ; Mynderse LA
Mayo Clin Proc; 2005 Oct; 80(10):1356-62. PubMed ID: 16212149
[TBL] [Abstract][Full Text] [Related]
14. Multichannel urodynamic studies in men with benign prostatic hyperplasia. Indications and interpretation.
Blaivas JG
Urol Clin North Am; 1990 Aug; 17(3):543-52. PubMed ID: 1695781
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality.
van Melick HH; van Venrooij GE; Eckhardt MD; Boon TA
J Urol; 2003 Apr; 169(4):1411-6. PubMed ID: 12629374
[TBL] [Abstract][Full Text] [Related]
16. [Benign prostatic hyperplasia--an old disease picture--from a new viewpoint].
Hartung R
Urologe A; 1995 Mar; 34(2):77-83. PubMed ID: 7538713
[No Abstract] [Full Text] [Related]
17. Noninvasive methods to evaluate bladder obstruction in men.
Elterman DS; Chughtai B; Lee R; Te AE; Kaplan SA
Int Braz J Urol; 2013; 39(1):4-9. PubMed ID: 23489514
[TBL] [Abstract][Full Text] [Related]
18. Benign prostatic hyperplasia: clinical manifestations and evaluation.
Santos Dias J
Tech Vasc Interv Radiol; 2012 Dec; 15(4):265-9. PubMed ID: 23244722
[TBL] [Abstract][Full Text] [Related]
19. BPH treatment: urodynamic preoperative assessment and evaluation.
Nordling J; Nielsen K
Arch Esp Urol; 1994 Nov; 47(9):838-46. PubMed ID: 7530939
[TBL] [Abstract][Full Text] [Related]
20. Patient selection and counseling before prostatic arterial embolization.
A Pereira J; Bilhim T; Duarte M; Rio Tinto H; Fernandes L; Martins Pisco J
Tech Vasc Interv Radiol; 2012 Dec; 15(4):270-5. PubMed ID: 23244723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
